A Bull Market Continues To Unfold On Tenaya Therapeutics Inc (NASDAQ: TNYA), As It Continued To Fall -67.13% In Year-To-Date

During the last session, Tenaya Therapeutics Inc (NASDAQ:TNYA)’s traded shares were 3.72 million, with the beta value of the company hitting 2.96. At the end of the trading day, the stock’s price was $0.47, reflecting an intraday gain of 3.30% or $0.01. The 52-week high for the TNYA share is $6.93, that puts it down -1374.47 from that peak though still a striking 17.02% gain since the share price plummeted to a 52-week low of $0.39. The company’s market capitalization is $37.24M, and the average trade volume was 4.01 million shares over the past three months.

Tenaya Therapeutics Inc (TNYA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. TNYA has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.31.

Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information

Tenaya Therapeutics Inc (TNYA) registered a 3.30% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.30% in intraday trading to $0.47, hitting a weekly high. The stock’s 5-day price performance is -53.00%, and it has moved by -54.37% in 30 days. Based on these gigs, the overall price performance for the year is -92.89%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.43%. While earnings are projected to return 19.60% in 2025, the next five years will return 11.39% per annum.

TNYA Dividends

Tenaya Therapeutics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 7.62 million shares, is of RA CAPITAL MANAGEMENT, L.P.’s that is approximately 8.8935% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $23.63 million.